WO2017156194A1 - Compositions et procédés pour inhiber l'endonucléase de la pa de l'arn polymérase de la grippe - Google Patents

Compositions et procédés pour inhiber l'endonucléase de la pa de l'arn polymérase de la grippe Download PDF

Info

Publication number
WO2017156194A1
WO2017156194A1 PCT/US2017/021457 US2017021457W WO2017156194A1 WO 2017156194 A1 WO2017156194 A1 WO 2017156194A1 US 2017021457 W US2017021457 W US 2017021457W WO 2017156194 A1 WO2017156194 A1 WO 2017156194A1
Authority
WO
WIPO (PCT)
Prior art keywords
unsubstituted
substituted
membered
independently
compound
Prior art date
Application number
PCT/US2017/021457
Other languages
English (en)
Inventor
David T. Puerta
Seth M. Cohen
Cy V. CREDILLE
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Publication of WO2017156194A1 publication Critical patent/WO2017156194A1/fr
Priority to US16/125,468 priority Critical patent/US10889556B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/717—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a seven- to twelve-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/38—Unsaturated compounds containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

L'invention concerne entre autres des inhibiteurs de métalloenzymes, tels que des inhibiteurs de l'endonucléase de la sous-unité PA de l'ARN polymérase ARN-dépendante de la grippe de type A, et des procédés de synthèse et d'utilisation de ceux-ci.
PCT/US2017/021457 2016-03-08 2017-03-08 Compositions et procédés pour inhiber l'endonucléase de la pa de l'arn polymérase de la grippe WO2017156194A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/125,468 US10889556B2 (en) 2016-03-08 2018-09-07 Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662305407P 2016-03-08 2016-03-08
US62/305,407 2016-03-08

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/125,468 Continuation-In-Part US10889556B2 (en) 2016-03-08 2018-09-07 Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease

Publications (1)

Publication Number Publication Date
WO2017156194A1 true WO2017156194A1 (fr) 2017-09-14

Family

ID=59789697

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/021457 WO2017156194A1 (fr) 2016-03-08 2017-03-08 Compositions et procédés pour inhiber l'endonucléase de la pa de l'arn polymérase de la grippe

Country Status (1)

Country Link
WO (1) WO2017156194A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109897007A (zh) * 2019-02-25 2019-06-18 天津国际生物医药联合研究院 二羟基嘧啶化合物及其应用
CN111205252A (zh) * 2020-02-10 2020-05-29 杭州科兴生物化工有限公司 具有神经氨酸酶抑制作用的sek15类聚酮化合物及其制备方法和应用
US10759814B2 (en) 2016-08-10 2020-09-01 Shionogi & Co., Ltd. Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof
WO2020227180A1 (fr) * 2019-05-03 2020-11-12 Saint Louis University Inhibiteurs de nucléotidyltransférases à base de tropolone de soufre et d'amide, et leurs utilisations
US10889556B2 (en) 2016-03-08 2021-01-12 The Regents Of The University Of California Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease
EP4045025A4 (fr) * 2019-10-16 2023-11-22 Kinesid Therapeutics, Inc. Dérivés de tropolone et leurs tautomères pour la régulation du fer chez les animaux

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050220895A1 (en) * 2003-12-17 2005-10-06 Bucalo Louis R Use of gallium to treat inflammatory arthritis
US20140079666A1 (en) * 2011-05-05 2014-03-20 St. Jude Children's Research Hospital Pyrimidinone compounds and methods for preventing and treating influenza
US20150322413A1 (en) * 2012-11-27 2015-11-12 Saint Louis University Hbv rnase h purification and enzyme inhibitors
US9260453B2 (en) * 2009-03-26 2016-02-16 Shionogi & Co., Ltd. Method for producing pyrone and pyridone derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050220895A1 (en) * 2003-12-17 2005-10-06 Bucalo Louis R Use of gallium to treat inflammatory arthritis
US9260453B2 (en) * 2009-03-26 2016-02-16 Shionogi & Co., Ltd. Method for producing pyrone and pyridone derivatives
US20140079666A1 (en) * 2011-05-05 2014-03-20 St. Jude Children's Research Hospital Pyrimidinone compounds and methods for preventing and treating influenza
US20150322413A1 (en) * 2012-11-27 2015-11-12 Saint Louis University Hbv rnase h purification and enzyme inhibitors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CORONA ET AL.: "Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6", PLOS ONE, vol. 11, no. 1, 2016, pages 1 - 18, XP055414154 *
CREDILLE ET AL.: "Fragment-Based Identification of Influenza Endonuclease Inhibitors", J. MED. CHEM., vol. 59, no. 13, 2016, pages 6444 - 6454, XP055414158, Retrieved from the Internet <URL:http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00628> [retrieved on 20170531] *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10889556B2 (en) 2016-03-08 2021-01-12 The Regents Of The University Of California Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease
US10759814B2 (en) 2016-08-10 2020-09-01 Shionogi & Co., Ltd. Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof
US11306106B2 (en) 2016-08-10 2022-04-19 Shionogi & Co., Ltd. Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof
CN109897007A (zh) * 2019-02-25 2019-06-18 天津国际生物医药联合研究院 二羟基嘧啶化合物及其应用
WO2020227180A1 (fr) * 2019-05-03 2020-11-12 Saint Louis University Inhibiteurs de nucléotidyltransférases à base de tropolone de soufre et d'amide, et leurs utilisations
EP4045025A4 (fr) * 2019-10-16 2023-11-22 Kinesid Therapeutics, Inc. Dérivés de tropolone et leurs tautomères pour la régulation du fer chez les animaux
CN111205252A (zh) * 2020-02-10 2020-05-29 杭州科兴生物化工有限公司 具有神经氨酸酶抑制作用的sek15类聚酮化合物及其制备方法和应用
CN111205252B (zh) * 2020-02-10 2021-10-29 杭州科兴生物化工有限公司 具有神经氨酸酶抑制作用的sek15类聚酮化合物及其制备方法和应用

Similar Documents

Publication Publication Date Title
US10889556B2 (en) Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease
WO2017156194A1 (fr) Compositions et procédés pour inhiber l&#39;endonucléase de la pa de l&#39;arn polymérase de la grippe
US10501439B2 (en) DNA-PK inhibitors
EP3428170B1 (fr) Dérivé de pyridone polycyclique anti-grippal et promédicament de celui-ci
AU2014337208B2 (en) DNA-PK inhibitors
CA2734415C (fr) Derives de picolinamide en tant qu&#39;inhibiteurs de kinase
EP2812001B1 (fr) Modulateurs d&#39;enzymes de modification par méthylation, leurs compositions et utilisations
EP3956033A1 (fr) Composés bicycliques
JP4771468B2 (ja) Ｓｒ蛋白質のリン酸化制御方法、および、ｓｒ蛋白質の活性制御剤を有効成分とする抗ウイルス剤
AU2018328818C1 (en) RAD51 inhibitors
CN109952300B (zh) 5或8-取代的咪唑并[1,5-a]吡啶
EP3240537A1 (fr) Nouvelles tétrahydropyridopyrimidines et tétrahydropyridopyridines pour le traitement et la prévention d&#39;une infection par le virus de l&#39;hépatite b
US20120225062A1 (en) Novel kinase inhibitors
CN113286794A (zh) Kras突变蛋白抑制剂
CA2717388A1 (fr) Inhibiteurs de pim kinase et leurs procedes d&#39;utilisation
WO2018157843A1 (fr) Inhibiteur fto de formiate aromatique 2-(matrice de benzène substitué), son procédé de préparation et ses applications
CZ301491B6 (cs) Pyrazolo[1,5-a]pyridiny a léciva s jejich obsahem
CA2756099A1 (fr) Derives de nicotinamide, leur preparation et leur application en therapeutique comme anticancereux
US20190262371A1 (en) Methods and composition for the treatment of rna viral infections
CA3143716A1 (fr) Methodes pour utiliser des inhibiteurs de rad51 pour le traitement du cancer du pancreas
WO2023022216A1 (fr) Dérivés nucléosidiques et leurs promédicaments ayant une action inhibitrice de la croissance virale
Xu et al. Discovery of novel substituted N-(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues as potent human adenovirus inhibitors
IL302698A (en) compounds and their uses
AU2017280293A1 (en) Mechanistic target of rapamycin signaling pathway inhibitors and therapeutic applications thereof
CN115286617B (zh) 一种靶向降解nampt的protac化合物及其应用

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17764052

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17764052

Country of ref document: EP

Kind code of ref document: A1